Duchenne muscular dystrophy
Duchenne muscular dystrophy is a severe, progressive, muscle-wasting disease that leads
to difficulties with movement and, eventually, to the need for assisted ventilation and …
to difficulties with movement and, eventually, to the need for assisted ventilation and …
The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review
S Ryder, RM Leadley, N Armstrong… - Orphanet journal of rare …, 2017 - Springer
Abstract Background Duchenne Muscular Dystrophy (DMD) is a rapidly progressive, lethal
neuromuscular disorder, present from birth, which occurs almost exclusively in males. We …
neuromuscular disorder, present from birth, which occurs almost exclusively in males. We …
The TREAT‐NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations
CL Bladen, D Salgado, S Monges… - Human …, 2015 - Wiley Online Library
Analyzing the type and frequency of patient‐specific mutations that give rise to Duchenne
muscular dystrophy (DMD) is an invaluable tool for diagnostics, basic scientific research …
muscular dystrophy (DMD) is an invaluable tool for diagnostics, basic scientific research …
The pathogenesis and therapy of muscular dystrophies
Current molecular genomic approaches to human genetic disorders have led to an
explosion in the identification of the genes and their encoded proteins responsible for these …
explosion in the identification of the genes and their encoded proteins responsible for these …
International cooperation to enable the diagnosis of all rare genetic diseases
Provision of a molecularly confirmed diagnosis in a timely manner for children and adults
with rare genetic diseases shortens their" diagnostic odyssey," improves disease …
with rare genetic diseases shortens their" diagnostic odyssey," improves disease …
Clinical outcomes in Duchenne muscular dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database
Z Koeks, CL Bladen, D Salgado… - Journal of …, 2017 - content.iospress.com
Background: Recent short-term clinical trials in patients with Duchenne Muscular Dystrophy
(DMD) have indicated greater disease variability in terms of progression than expected. In …
(DMD) have indicated greater disease variability in terms of progression than expected. In …
The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review
SM Szabo, RM Salhany, A Deighton… - Orphanet Journal of …, 2021 - Springer
Background Duchenne muscular dystrophy (DMD) is a severe rare progressive inherited
neuromuscular disorder, leading to loss of ambulation (LOA) and premature mortality. The …
neuromuscular disorder, leading to loss of ambulation (LOA) and premature mortality. The …
The burden of Duchenne muscular dystrophy: an international, cross-sectional study
E Landfeldt, P Lindgren, CF Bell, C Schmitt, M Guglieri… - Neurology, 2014 - AAN Enterprises
Objective: The objective of this study was to estimate the total cost of illness and economic
burden of Duchenne muscular dystrophy (DMD). Methods: Patients with DMD from …
burden of Duchenne muscular dystrophy (DMD). Methods: Patients with DMD from …
Current and emerging treatment strategies for Duchenne muscular dystrophy
JK Mah - Neuropsychiatric disease and treatment, 2016 - Taylor & Francis
Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy in
childhood. It is caused by mutations of the DMD gene, leading to progressive muscle …
childhood. It is caused by mutations of the DMD gene, leading to progressive muscle …
Quantifying the burden of caregiving in Duchenne muscular dystrophy
E Landfeldt, P Lindgren, CF Bell, M Guglieri… - Journal of …, 2016 - Springer
Duchenne muscular dystrophy (DMD) is a rare pediatric neuromuscular disease associated
with progressive muscle degeneration and extensive care needs. Our objective was to …
with progressive muscle degeneration and extensive care needs. Our objective was to …